Anishiya Abrol

Anishiya Abrol

Counsel, Washington, D.C.

Email anishiya.abrol@​hoganlovells.com

Phone +1 202 637 6950

Fax +1 202 637 5910

Practice groupIntellectual Property

Anishiya Abrol supports companies in their development and commercialization of cutting-edge medical therapies and tools. She advises on and negotiates a variety of strategic transactions from collaborations to in-licensing and out-licensing to maximize intellectual property assets, and then assists the company in implementing and integrating the new assets.

Anishiya has been seconded to multiple life sciences companies. She knows the issues facing in-house counsel and works closely with members of the firm's Regulatory and Privacy Practice Groups to provide integrated and practical advice.

Anishiya's practice encompasses the full life sciences life cycle, from the discovery in the lab to dispensing to a patient. She has an undergraduate science degree, and her curious nature draws her towards early stage research and development transactions and activities, including clinical trial agreements, material transfer agreements, CRO agreements, core lab agreements, sponsored research, grants, and technology transfers, both domestically and internationally. Recognizing though that a therapy's primary value lies in the hands of patients, she assists commercialization efforts with support on distribution agreements, specialty pharmacy agreements, co-promotion agreements, authorized generic agreements, out-licensing arrangements, and other similar commercial activities.

Awards and recognitions

2017

Healthcare: Life Sciences, Next Generation
Legal 500 US

Education and admissions

Education

J.D., George Mason University School of Law, magna cum laude, 2004

B.A. Biology, University of Virginia, 1997

B.A. History, University of Virginia, 1997

Memberships

Chair, Wills for Heroes Program, Virginia Bar Association (2008-2013)

Member, American Health Law Association

Member, Virginia Bar Association

Bar admissions and qualifications

District of Columbia

Virginia

Representative experience

Regularly counsels on and oversees the conduct of global clinical studies.

Advised Novartis AG in connection with its divestment of its animal health business.

Advised Novartis AG in connection with its purchase of oncology assets from GSK.

Loading data